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Abstract
Objectives—As Asian Americans are disproportionately affected by the hepatitis B virus 
(HBV), this study explores predictors of HBV screening and vaccination among Chinese and 
Korean Americans.
Methods—This study uses cross-sectional data from a community-based sample of Chinese 
Americans (N = 502) and Korean Americans (N = 487) residing in the metropolitan New York 
City area from 2008–2009. Logistic regression models were stratified by Asian American 
subgroup and sex to predict HBV screening (among the entire sample) and HBV vaccination 
(among those not HBV positive).
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Results—Overall, screening rates were high (71.3% among Chinese and 70.1% among Koreans). 
The majority of respondents were aware of HBV; however, knowledge about HBV transmission 
was low. In logistic regression, a physician recommendation was consistently associated with 
HBV screening and vaccination outcomes across all groups; having heard of HBV was 
significantly associated with screening and vaccination among Chinese males and screening 
among Korean males and females. Screening and vaccination barriers were reported among all 
groups, and include lack of knowledge and feeling well/having no health issues.
Conclusions—Targeted efforts in these at-risk communities are necessary in order to improve 
HBV knowledge, address misinformation about HBV, and eliminate provider-, patient-, and 
resource-related barriers to HBV screening and vaccination.
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Hepatitis B is a potentially life-threatening but preventable liver infection caused by the 
hepatitis B virus (HBV). Globally, about 2 billion people have been infected with HBV and 
350 million live with chronic HBV infection, which is responsible for 600,000 deaths 
annually.1 Nationally, between 800,000 and 2 million persons are infected with HBV in the 
United States (US).2–6 Asian Americans (AAs) account for more than 50% of those 
infected,7 despite making up only 6.2% of the total US population, alone or in combination 
with other races.8 HBV and associated liver cancer in AAs and Native Hawaiians, Pacific 
Islanders (NHPIs) represents one of the most serious health disparities in the US; the death 
rate from HBV among AAs and NHPIs is 7 times greater than the rate among Whites,9 and 
among AAs, the incidence of hepatocellular carcinoma is approximately 4 times higher than 
among Whites.10
Chinese and Korean Americans, the first and fifth largest AA subgroups,8 exhibit high 
prevalence of HBV infection. A community-based study in New York City (NYC) found 
that among Chinese Americans screened for HBV, self-reported HBV prevalence was 
9.9%.11 A seroprevalence study conducted between 2004 and 2008 in NYC found that the 
prevalence of chronic HBV infection was between 21.4% and 23.2% among newly screened 
Chinese-born individuals and 3.8% to 4.6% among newly screened Korean-born 
individuals.12,13 Studies in US locations outside of NYC have also documented high HBV 
prevalence among Chinese Americans, between 5.5% and 21%,14–18 and studies among 
Korean Americans report a prevalence between 0.7% and 17.9%.15,18–22
Despite the high prevalence of HBV among Chinese and Korean Americans, screening rates 
are low, ranging from 37% to 55% among Chinese Americans,11, 15, 23–25 and from 32% to 
56% among Korean Americans.15,26,27 It is likely that many who are infected are unaware of 
their status, downplaying the HBV infection rate among these groups; many of those who do 
not report infection may simply be unaware of their infection risk, by having not been 
screened. Compared with screening rates, vaccination rates among susceptible individuals 
are also very low, ranging from 31% to 46% among Chinese Americans11,15,25 and from 
25% to 37% among Korean Americans.15,22
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Given that HBV screening and vaccination prevent and control liver disease, it is important 
to understand the factors that may influence these behaviors among particular subgroups. 
Previous research in Chinese- and Korean-American communities has found important 
individual-level facilitators to be associated with higher HBV screening rates, including 
greater levels of HBV knowledge23,26,28,29 and a family history of HBV.29 Socio-
demographics such as older age, higher education,28,29 greater time lived in the US,29 and 
greater English language proficiency23,28 may also contribute to screening and vaccination 
behaviors. Health coverage and associated factors may also play an important role; a 
physician recommendation or asking a physician about screening may increase HBV 
screening and vaccination,23,26,29 as well as having health insurance11,30 or having a 
primary health care provider.30
AAs are one of the fastest growing populations in the US, and by 2060 Asians alone or in 
combination with other groups will represent 11.7% of the population.31 The purpose of our 
study was to: (1) assess HBV screening and vaccination behaviors among Chinese and 
Korean Americans in NYC; (2) identify factors that impact HBV screening and vaccination 
among these subgroups; and (3) identify additional barriers and facilitators to screening and 
vaccination. Guided by the Health Belief Model, we hypothesize that perceived 
susceptibility, barriers, cues to action, HBV knowledge, health care access, and education 
will be associated with screening and vaccination behaviors among our Chinese and Korean 




B Free CEED, a community-based participatory research (CBPR) study funded by the US 
Centers for Disease Control and Prevention, Racial and Ethnic Approaches to Community 
Health (REACH) program, was led by an academic-community partnership composed of an 
academic organization and 2 key community partners focused in the Korean- and Chinese-
American communities.32,33 In order to inform a social marketing campaign to increase 
HBV awareness, surveys were collected from 2008 to 2009 using street-intercept and venue-
based sampling to inform HBV awareness and behaviors among Chinese- and Korean-
American immigrants living in NYC. These methods have shown good feasibility and are 
able to produce robust samples, especially among historically “hard-to reach” 
populations.34–36
The survey used convenience sampling implemented via a targeted, venue-based sampling 
method in community settings to reach the largely immigrant Chinese- and Korean-
American population. Eligibility included: (1) self-identification as Chinese or Korean; (2) 
aged 18 and over; and (3) living in the New York metropolitan area. Prior to data collection, 
an environmental scan identified areas in NYC where at-risk Chinese and Korean 
immigrants were most likely to live, work, or shop. Findings from formative research, 
including a literature review, analyses of census data, and discussions with community-based 
partners, was used to identify characteristics of Chinese and Korean Americans at high risk 
of infection and informed the selection of survey sites. These included street corners, 
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storefronts, shopping malls, and churches in Manhattan Chinatown, Korea Town in Midtown 
Manhattan, and Flushing Queens. When assessing the feasibility of surveying at the 
proposed locations, the following things were considered: the level of foot traffic at different 
times, the diversity of individuals passing, and safety. Various time frames were also selected 
(eg, weekday mornings, weekend afternoons) in order to obtain a diverse sample. Using a 
systematic sampling method, surveyors stood at a pre-identified marker at each location (eg, 
a fire hydrant, mailbox) and invited every third person who passed the marker to participate 
in the survey. Using a CBPR approach, we agreed on the total number of surveys to obtain.
Based on our formative research, we applied purposive sampling methods to target 
community venues where high-risk subgroups, including young, male Chinese immigrants 
from the Fujian province13 were more likely to congregate (eg, faith-based organizations and 
areas near employment offices). Surveys were administered in English, Cantonese, 
Mandarin, and Korean languages. All surveyors were trained as a group during a 1–1/2-hour 
training session. Surveys were initially written in English and then were translated into 
Chinese and Korean languages. The translations were reviewed by native language speakers, 
and consensus was used to address any issues or discrepancies. The surveys were 
anonymous, and no identifiers were collected. Upon completion of the survey, participants 
received a $10 gift card for a local bakery or supermarket. The final sample included 502 
Chinese Americans and 487 Korean Americans.
Theoretical Framework
The theoretical framework for the CBPR project includes the Health Belief Model,37, 38 
Social Learning Theory38,39 and the principles of social marketing.40 Together, these 
theories helped to inform the development of the survey measures and the selection of 
variables for statistical modeling. Briefly, the Health Belief Model posits that health-related 
action is a function of perceived susceptibility, perceived severity, perceived benefits, and 
perceived barriers; in other words, higher perceived risk leads to greater preventive 
behaviors. Social Learning Theory hypothesizes that health behaviors are affected by 
expectancies, such as environmental cues, consequences of one’s own actions, and one’s 
own competence to perform the needed behavior, as well as incentives, or the value of the 
outcome.38 Finally, social marketing principles help to explicate and understand the 
perceived costs and benefits of behavior change and decision-making in public health 
programs.
Dependent Variables
Respondents were asked, “Have you been screened/tested for HBV?” and “Have you been 
vaccinated for HBV?” The screening outcome was examined among the entire sample, and 
the vaccination outcome was examined out of those reporting that they had not been 
diagnosed with HBV (those at risk for HBV).
Independent Variables
Socio-demographics—Socio-demographic questions were adapted from the Behavioral 
Risk Factor Surveillance Survey (BRFSS).41 Socio-demographic information included sex, 
age (continuous), marital status, education (categories differed for Chinese and Korean 
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groups), foreign-born, province (for Chinese only), years lived in U.S (continuous), percent 
of lifetime lived in US (years lived in the US divided by current age, US-born counts as 
100%), spoken English fluency, and self-rated health status.
Resource and provider variables—Resource and provider barriers included health 
insurance status and cues to action as measured by a physician HBV screening or 
vaccination recommendation.
HBV knowledge—Respondents were asked if they had ever heard of HBV. Knowledge of 
HBV and HBV transmission were measured using 10 questions adapted from previous 
research studies.23,42,43 One question asked “In which ethnic group is HBV most common,” 
and 9 additional questions asked about ways in which HBV can be transmitted. Respondents 
scored one point for each correct answer, for a total of 10 points. Individuals answering 
“don’t know” for transmission route received no points for these questions. Total scores 
ranged from 0 (no correct answers) to 10 (all correct answers).
Familial factors—Respondents were asked if a friend or family member had 
recommended HBV screening or vaccination.
Perceived susceptibility—Perceived HBV susceptibility was assessed by asking the 
respondent if they thought that they could be infected with HBV.
Barriers and Facilitators to HBV Screening and Vaccination
Respondents answering “no” to HBV screening or vaccination were asked to choose reasons 
why they were not screened or vaccinated. Potential barriers were assessed at 3 levels: 
resource related, individual level, and provider level. All respondents were asked, “What 
influenced or would influence you to get HBV screening and vaccination?” All potential 
barriers and facilitators to screening and vaccination are listed in tables 4 and 5.
Data Analyses
Given that prior research indicates that HBV prevalence and screening/vaccination behaviors 
vary by ethnicity and sex among Asian Americans,44 analyses were conducted separately by 
Chinese and Korean Americans, and then stratified by sex within each group. Sample 
characteristics were analyzed for Chinese and Korean Americans, overall and by sex. 
Prevalence of HBV screening, screening outcome (among those screened), and vaccination 
(among those not HBV positive) were analyzed for Chinese and Korean Americans. 
Multivariable logistic regression models were utilized to identify factors associated with 
screening and vaccination behaviors; odds ratios (ORs), 95% confidence intervals (CIs), and 
p-values are presented, and associations were considered significant at p ≤ .05. Finally, 
barriers to screening and vaccination were analyzed descriptively among all unscreened and 
unvaccinated individuals, and potential factors influencing HBV screening and vaccination 
were analyzed among screened and unscreened individuals; frequencies are presented. All 
data was analyzed using IBM SPSS 21.0.45
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Socio-demographics of Chinese and Korean American Respondents
Table 1 presents the socio-demographic characteristics and HBV-related variables (resource 
and provider variables, HBV knowledge, familial factors, HBV beliefs, and perceived 
susceptibility) of the Chinese- and Korean-American respondents, overall and stratified by 
sex.
Among Chinese Americans, females differed from males in many aspects; for example, 
females were significantly more likely than males to be older, married or living with a 
partner, have lived in the US for longer, or have less than a high school education. Females 
were significantly less likely than males to be born in the Fujian province. In terms of HBV 
knowledge, females were significantly more likely to have heard of HBV. Additionally, 
Chinese females were more likely to have health insurance or to have received physician or 
family/friend screening and vaccination recommendation.
Among Korean Americans, females were significantly more likely than males to have less 
than a college education and speak English not well or not at all. Females were also more 
likely to have fair or poor health self-rated health. No significant differences were shown for 
resource and provider barriers or HBV knowledge across sex.
Screening and Vaccination Behaviors
Of the 502 Chinese-American respondents, 71.3% self-reported screening for HBV (67.6% 
of males and 76.3% of females). Of the 487 Korean-American respondents, 70.1% self-
reported screening for HBV (70.4% of males and 70.0% of females). Among screened 
Chinese Americans, 8.3% self-reported HBV infection (12.0% of males and 4.3% of 
females); among screened Korean Americans, 13.0% self-reported HBV infection (13.1% of 
males and 13.0% of females). After exclusion of respondents reporting HBV infection, 
60.7% of Chinese Americans had been vaccinated (55.8% of males and 66.7% of females), 
and 60.2% of Korean Americans had been vaccinated (60.4% of males and 60.2% of 
females). Table 1 shows these data.
Multivariable Associations with Screening and Vaccination
Bivariate analyses with screening and vaccination helped to inform the selection of variables 
included in multivariable models (data available upon request). Table 2 presents 
multivariable logistic regression models for HBV screening and vaccination among Chinese 
respondents, stratified by sex and adjusting for all variables in the model.
Results showed differences in factors associated with HBV screening and vaccination 
among Chinese-American males and females, while adjusting for all variables in the model. 
Among Chinese-American males, factors significantly associated with HBV screening 
included: being insured (OR: 2.5, 95% CI: 1.3–5.0), having heard of HBV (OR: 4.9, 95% 
CI: 1.9–12.3), and a physician screening recommendation (OR: 13.7, 95% CI: 5.6–33.6); in 
comparison, only a physician screening recommendation was significantly associated with 
HBV screening (OR: 12.3, 95% CI: 5.4–28.1) among Chinese females.
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Among Chinese-American males, factors significantly associated with HBV vaccination 
included: younger age (OR: 0.97, 95% CI: 0.93–1.00), a high school or vocational school 
education in comparison to less than high school (OR: 3.2, 95% CI: 1.2–8.0), a physician 
vaccination recommendation (OR: 47.0, 95% CI: 17.1–129.3), and having heard of HBV 
(OR: 7.2, 95% CI: 2.0–26.0). Among Chinese-American females, only a physician 
vaccination recommendation (OR: 15.6, 95% CI: 6.9–35.4) was significantly associated with 
HBV vaccination.
Table 3 presents multivariable logistic regression models for HBV screening and vaccination 
among Korean-American respondents, stratified by sex and adjusting for all variables in the 
model.
Among Korean-American males, factors significantly associated with HBV screening 
included: college graduate or higher (OR: 2.7, 95% CI: 1.2–6.0), having heard of HBV (OR: 
3.8, 95% CI: 1.2–12.5), and a physician screening recommendation (OR: 6.4, 95% CI: 2.5–
16.2). Among Korean-American females, factors significantly associated with HBV 
screening included: having heard of HBV (OR: 7.7, 95% CI: 2.2–26.9) and a physician 
screening recommendation (OR: 14.2, 95% CI: 4.0–51.1).
Among Korean Americans, HBV vaccination was significantly associated with a physician 
recommendation for both males (OR: 12.3, 95% CI: 4.8–31.7) and females (OR: 40.6, 95% 
CI: 9.0–182.8).
Barriers to HBV Screening and Vaccination
Further descriptive analyses were conducted to uncover barriers to screening and vaccination 
(see Table 4). Among unscreened Chinese Americans, the biggest barriers to screening 
included: feeling well/no health problems (40.6% of males and 32.5% of females), not 
suggested by a doctor (32.5% of females), lack of knowledge (30.4% of males and 15.0% of 
females), and no insurance (21.7% of males). Among unscreened Korean Americans, the 
biggest barriers to screening included: feeling well/no health problems (45.5% of males and 
53.1% of females), not suggested by a doctor (25.5% of males), lack of knowledge (32.7% 
of males and 18.4% of females), no time (25.5% of males), and didn’t know where to get 
screened (25.5% of males).
Among unvaccinated Chinese Americans, the biggest barriers to vaccination included: 
feeling well/no health problems (39.2% of males and 30.6% of females), followed by not 
suggested by a doctor (32.7% of females) and lack of knowledge (23.0% of males). Among 
unvaccinated Korean Americans, the biggest barriers to vaccination included: feeling 
well/no health problems (46.0% of males and 56.9% of females), lack of knowledge (27.0% 
of males and 32.3% of females), didn’t know to get vaccinated (15.9% of males), and not 
suggested by a doctor (15.4% of females).
Facilitators to HBV Screening
Table 5 includes the main factors that influenced screening/vaccination among screened 
respondents and would influence screening/vaccination among unscreened respondents. 
Among screened Chinese Americans, the main factors influencing HBV screening and 
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vaccination included the following: a doctor told you to get screened (54.9% of males and 
68.3% of females. The main factors that would influence HBV screening and vaccination 
among unscreened Chinese Americans included: a doctor told you to get screened (42.0% of 
males and 52.9% of females).
Among screened Korean Americans, the main factors influencing HBV screening and 
vaccination included: a doctor told you to get screened (58.0% of males and 55.8% of 
females); having a family member who is a carrier (33.5% of males and 34.4% of females); 
free screening/covered by insurance (25.0% of males and 27.9% of females); and 
encouragement by family members (25.6% of males and 22.1% of females). Among 
unscreened Korean Americans, the main factors that would influence HBV screening and 
vaccination included: a doctor told you to get screened (39.2% of males and 51.5% of 
females); fear of being infected by the virus (20.3% of males); having a family member who 
is a carrier (39.2% of males and 39.4% of females); free screening/covered by insurance 
(31.1% of males and 27.3% of females); encouragement by family members (28.4% of 
males); and encouragement by spouse (21.6% of males and 24.2% of females).
DISCUSSION
Using data from a CBPR project in AA immigrant communities in NYC, this study found 
that overall HBV screening rates were 71.3% among Chinese Americans (males: 67.6% and 
females: 76.3%) and 70.1% among Korean Americans (males: 70.4% and females: 70.0%). 
Vaccination rates were 60.7% among Chinese Americans (males: 55.8% and females: 
66.7%) and 60.2% among Korean Americans (males: 60.4% and females: 60.2%). Our 
findings indicate higher rates of HBV screening and vaccination among Chinese and Korean 
Americans in metropolitan New York compared with studies in other locations, where HBV 
screening rates range from 35.0% to 54.5%11,15,23–25 and vaccination rates range from 
24.7% to 45.6%.11,15,22,24,25 This may be related, in part, to the community-based, city-wide 
HBV screening programs in NYC that were conducted between 2005 and 2008.13,46 In 
addition, our findings showed that socio-demographic variables are not uniformly associated 
with screening and vaccination. For example, younger age and having a high school 
education (in comparison to less than a high school education) was associated with HBV 
vaccination among Chinese males, while having insurance was significantly associated with 
HBV screening among Chinese males. Being a college graduate was associated with HBV 
screening among Korean males, but not Korean females. These findings underscore the 
importance of stratifying subgroups by ethnicity and sex.
Similar to past literature, our study found that a physician recommendation was significantly 
associated with screening and vaccination outcomes among all subgroups.23,29 Cues to 
action, in particular physician recommendation, can be a powerful catalyst for health 
behavior change. Among Chinese Americans screened for HBV, 56.3% of males and 76.2% 
of females reported receiving a physician’s recommendation, and among Korean Americans 
screened for HBV, 43.4% of males and 44.8% of females reported receiving a physician’s 
recommendation. Similar results were shown for vaccination recommendations among 
vaccinated Chinese- and Korean-American respondents (results available upon request). 
Other cues to action, including encouragement by a family member, a friend or a spouse, or 
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having a family member who is a carrier were also found to be factors that contribute to 
HBV screening and vaccination, but these were not as influential as a physician’s 
recommendation. Previous studies have found that physician recommendations are 
significantly correlated with medical action among AA women, including with mammogram 
and breast self-exam among low income women aged 40 and older47 and with Pap 
testing.48–50 Interventions and campaigns that educate and encourage physicians to 
recommend HBV screening and vaccination for their Chinese and Korean patients may be 
particularly effective, especially as many physicians may not be aware of these 
recommendations.51,52
The findings also indicate that the majority of Chinese- and Korean-American respondents 
had heard of HBV; this awareness was significantly associated with HBV screening and 
vaccination among Chinese males, as well as among Korean males and females. Consistent 
with prior studies, however, knowledge of HBV and HBV transmission was low among both 
groups.25,53,54 Although the multivariable analysis did not find that knowledge of HBV 
transmission was significantly associated with screening or vaccination, knowledge of HBV 
was a major barrier for HBV screening and vaccination among both Chinese and Korean 
Americans. Korean Americans also reported low levels of HBV knowledge for particular 
transmission questions (eg, unprotected sex, an infected mother to her baby at the time of 
delivery, using contaminated needles). Education and awareness campaigns and 
interventions, including the use of community health workers, for example, may increase the 
knowledge of HBV transmission among high-risk AA populations.
Our study identifies important barriers to HBV screening and vaccination among unscreened 
and unvaccinated individuals. Overall, Chinese- and Korean-American males reported more 
barriers than females; in particular, feeling well or having no health problems and a lack of 
knowledge about HBV were important barriers among all groups, but greater among males. 
In addition, Chinese-American males were more likely to report barriers such as no 
insurance and not knowing where to get screened or vaccinated. Conversely, many women 
reported not receiving a physician recommendation as a barrier. The most salient barrier was 
perceived susceptibility of HBV infection. This is consistent with the Health Belief Model, 
whereby high-perceived susceptibility motivates individuals to adopt preventive measures 
such as HBV screening and vaccination. Further understanding of these barriers will help 
avoid the formation of a barrier cycle which prevents HBV screening and vaccination among 
AAs.55
Additionally, important factors influencing HBV screening and vaccination were identified. 
In particular, a physician’s screening recommendation was an important facilitator across 
both subgroup and sex. Additionally, having a family member who is a carrier, free 
screening or vaccination if covered by insurance, and attending an HBV educational 
workshop were important influencers of screening behaviors among Korean-American 
respondents.
Our study has significant implications for efforts to eliminate HBV disparities among AAs. 
It highlights the need for differential strategies to promote HBV screening and vaccination 
among Chinese- and Korean-American populations, especially in large urban cities where 
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AA immigrant populations are concentrated. Given the diversity of AA subgroups, a multi-
pronged approach that includes diverse partnerships and community-based strategies is 
needed to properly address this health disparity.13,29,32,46,56 Based on our findings, this 
approach should include strategies that not only target misinformation about HBV, but also 
address provider-, patient-, and resource-related barriers.57 One possible strategy is social 
marketing, as an increasing body of research has shown its effectiveness in improving 
various health-related behavior risk factors across a range of targeted groups.58–61 Using 
commercial marketing techniques and principles to bring about changes in health behaviors, 
social marketing can help develop meaningful and culturally appropriate messages for 
healthcare providers to increase their recommendations for HBV screening and vaccination 
among AAs; additionally, social marketing can help Chinese and Korean Americans to 
enhance their awareness, knowledge and perceived susceptibility to HBV infection.
The findings of this study should be interpreted with several limitations. First, the cross-
sectional design limits any determination of causality between variables. Second, the data 
are self-reported, and there may be an underestimate of HBV infection due to the fear of the 
stigma attached to a diagnosis of HBV and unknown HBV status among unscreened 
individuals.62 Studies collecting clinical data, such as hepatitis B surface antigen (HBsAg), 
are needed in AA populations to produce more precise estimates of HBV prevalence. Third, 
our study results may not be generalizable to other AA populations in the US Guided by our 
review of the literature on risk factors for HBV infection; we oversampled young Chinese 
males, especially those born in the Fujian province. Therefore, our male Chinese-American 
respondents are more generalizable to this specific subgroup. Our method, including the use 
of a CBPR approach, however, was key in surveying this at-risk, hard-to-reach, largely 
immigrant population. Finally, additionally predictor variables, such as a family history of 
HBV and previously validated knowledge scale measures were not included which may have 
limited our ability to detect significant findings.
Given that AAs are disproportionately affected by HBV infection and liver cancer more than 
any other racial/ethnic group in the US, approaches for increasing HBV screening and 
vaccination among AAs, particular among Chinese and Korean Americans, should be a 
priority in public health policy and research. This study provides a more comprehensive 
analysis of HBV screening and vaccination behaviors and their correlates among Chinese 
and Korean Americans in the NYC area. Our findings may help to inform the development 
of strategies to reduce this health disparity among at-risk populations, specifically by 
prioritizing provider-related resources and targeted strategies to help increase screening and 
vaccination efforts for high-risk populations.
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